Chongqing Kangle Pharmaceutical Co., Ltd.

FDA inspection history across 2 sites, 2015 to 2018

2
Form 483s

Every document, by year

  • Form 483

2015: one Form 483; 2018: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015One Form 483, at Chongqing (Changshou), China.
  2. 2015The longest 483 on file: 2 observations over 2 pages at Chongqing (Changshou), China.
  3. 2018One Form 483, at Chongqing, China.

Cited most

Across all Chongqing Kangle Pharmaceutical Co. observations on file

The complete Chongqing Kangle Pharmaceutical Co. file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2018-07-26483 Form 483$99
2015-01-26483 Form 483$99

Investigators on these documents

Nadeem I. Chaudhry (1)

FEI number 3007088564 · most recent document Jul 26, 2018

About Chongqing Kangle Pharmaceutical Co., Ltd.

How many FDA Form 483s has Chongqing Kangle Pharmaceutical Co., Ltd. received?

FDA Intel has 2 Form 483s on file for Chongqing Kangle Pharmaceutical Co., Ltd.; the most recent is dated Jul 26, 2018.

When was Chongqing Kangle Pharmaceutical Co., Ltd. last inspected by FDA?

The most recent FDA inspection document on file for Chongqing Kangle Pharmaceutical Co., Ltd. is a Form 483 dated Jul 26, 2018, for the site in Chongqing, China.

What did FDA cite at Chongqing Kangle Pharmaceutical Co., Ltd.?

The regulations cited most in the observations on file for Chongqing Kangle Pharmaceutical Co., Ltd. are 21 CFR 211.46 (Ventilation, air filtration, air heating and cooling), 2 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.

Chongqing Kangle Pharmaceutical Co., Ltd. FDA 483s · FDA Intel